Product Description: Brodalumab (AMG 827) is a human anti-interleukin-17-receptor IgG2 monoclonal antibody that can be used for the research of moderate-to-severe plaque psoriasis and rheumatoid arthritis[1][2].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Papp KA, et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012 Mar 29;366(13):1181-9./[2]Martin DA, et al. A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis. Arthritis Res Ther. 2013 Oct 25;15(5):R164.
CAS Number: 1174395-19-7
Molecular Weight: N/A
Compound Purity: 97.23
Research Area: Inflammation/Immunology
Solubility: H2O
Target: Interleukin Related